These challenges include degradation by cellular nucleases, high renal clearance, and low penetration in biological membranes due to their negative charge
Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
For aqueous peptide solutions at volumes under 0.5 mL, 29, 31G meets that threshold consistently
But it's the rise of GLP-1 medications that the most recent Gallup National Health and Well-Being Index credited for a drop in the U.S
From my perspective as a physician specializing in obesity medicine, GLP-1 medications like semaglutide have truly changed the game